ISPERSE Trademark

Trademark Overview


On Tuesday, December 5, 2023, a trademark application was filed for ISPERSE with the United States Patent and Trademark Office. The USPTO has given the ISPERSE trademark a serial number of 98299991. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, September 3, 2024. This trademark is owned by PULMATRIX OPERATING COMPANY, INC.. The ISPERSE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system
isperse

General Information


Serial Number98299991
Word MarkISPERSE
Filing DateTuesday, December 5, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, September 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 3, 2024

Trademark Statements


Description of MarkThe mark consists of the wording "ISPERSE" in stylized font, of which "I" appears in light blue, "SPERSE" in blue, and the tittle of "I" in turquoise color.  This wording has an underline in blue and light blue colors.
Goods and ServicesPharmaceuticals used for the treatment and prevention of diseases, disorders and conditions of the pulmonary system, and for the treatment and prevention of exacerbations of these diseases, disorders and conditions; pharmaceuticals used for the treatment and prevention of infections; pharmaceuticals used for the treatment and prevention of headaches and neurological conditions; drug delivery agents comprising formulations that facilitate delivery of a wide range of pharmaceuticals to the pulmonary system; drug delivery agents comprising formulations that facilitate systemic delivery of a wide range of pharmaceuticals by way of the pulmonary system
Pseudo MarkI SPERSE
Indication of Colors claimedThe color(s) blue, light blue, and turquoise is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, December 5, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePULMATRIX OPERATING COMPANY, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBedford, MA 01730

Party NamePULMATRIX OPERATING COMPANY, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBedford, MA 01730

Trademark Events


Event DateEvent Description
Tuesday, December 5, 2023NEW APPLICATION ENTERED
Friday, March 1, 2024NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, March 1, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 31, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, July 31, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, July 31, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, July 31, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 31, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 14, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 3, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 3, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024ASSIGNED TO EXAMINER